Bone mass and the risk of colon cancer among postmenopausal women: The Framingham Study

American Journal of Epidemiology

Volumn 153, Issue 1, 2001, Pages 31-37

  Zhang, Yuqing ^a,i   Felson, David T ^a   Ellison, R Curtis ^a   Kreger, Bernard E ^a,b,c   Schatzkin, Arthur ^d   Dorgan, Joanne F ^e   Cupples, L Adrienne ^f   Levy, Daniel ^a,b   Kiel, Douglas P ^g,h  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FRAMINGHAM HEART STUDY   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e FOX CHASE CANCER CENTER   (United States)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^g RESEARCH AND TRAINING INSTITUTE   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone density; Cohort studies; Colorectal neoplasms; Estrogens

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; BONE ATROPHY; BONE DENSITY; BONE MASS; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; COLON CANCER; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; POSTMENOPAUSE; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; COHORT STUDIES; COLONIC NEOPLASMS; ESTROGENS; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MASSACHUSETTS; MIDDLE AGED; POSTMENOPAUSE;

EID: 0035156721     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/153.1.31     Document Type: Article

References (52)

1. Reproduction, endogenous and exogenous sex hormones and colon cancer: A review and hypothesis
2. Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors
3. Reproductive factors and colon cancer
4. The influence of parity and exogenous female hormones on the risk of colorectal cancer
5. Postmenopausal hormone use and risk of large-bowel cancer
6. Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA)
7. Reproductive factors, exogenous female hormones, and colorectal cancer by subsite
8. Hormone replacement therapy, reproductive history, and colon cancer: A multicenter, case-control study in the United States
9. Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer
10. A case-control study of large bowel cancer and hormone exposure in women
11. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women
12. Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States)
13. Alcohol, physical activity and other risk factors for colorectal cancer: A prospective study
14. Menopausal hormone use and colorectal cancer in Saskatchewan: A record linkage cohort study
15. Risk of cancer in women receiving hormone replacement therapy
16. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy: Long-term follow-up of Swedish cohort
17. A prospective study of menopausal hormones and risk of colorectal cancer (United States)
18. Postmenopausal hormone use and colorectal cancer and adenoma
19. A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women
20. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women
21. Parity and colorectal risk in women
22. Reproductive risk factors for colorectal adenomatous polyps (New York City, NY, United States)
23. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: The Minnesota Cancer Prevention Research Unit case-control study
24. Recent use of hormone replacement therapy and the prevalence of colorectal adenomas
25. Regulation of bone cell function by gonadal steroids
26. Possible estrogenic effect on bone in postmenopausal patients with mammary carcinoma
27. Reduced risk of breast and endometrial cancer among women with hip fractures
28. Reduced cancer morbidity and mortality in a prospective cohort of women with distal forearm fractures
29. Non-trauma mortality in elderly women with low bone mineral density: Study of Osteoporotic Fractures Research Group
30. Bone mineral density and risk of breast cancer in older women: The Study of Osteoporotic Fractures
31. Bone mass and the risk of breast cancer among post-menopausal women: The Framingham Study
32. The cancer experience in the Framingham Heart Study cohort
33. Physical activity and risk of large bowel cancer in the Framingham Study
34. Loss of compact bone due to menopause
35. Quantum concept of bone remodeling and turnover: Implications for the pathogenesis of osteoporosis
36. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa
37. Total and regional bone mineral content in women treated with GnRH agonists
38. Perimenopausal appendicular bone loss: A 10-year prospective study
39. Sex hormone binding globulin in postmenopausal women: A predictor of osteoporosis superior to endogenous estrogens
40. Endogenous estrogen levels and calcium intakes in postmenopausal women: Relationships with cortical bone measure
41. The relationship of endogenous estrogen to bone density and bone area in normal postmenopausal women
42. Endogenous sex hormones and bone mineral density among community-based postmenopausal women
43. Endogenous hormones and risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group
44. Menopausal estrogen therapy and hip fractures
45. Long-term estrogen replacement therapy prevents bone loss and fractures
46. The effect of postmenopausal estrogen therapy on bone mineral density in elderly women
47. Postmenopausal hormone therapy and risk of colorectal cancer: A review and meta-analysis
48. The physiochemical basis of cholesterol gallstone formation in man
49. Production of diacylglycerol, an activator of protein kinase C, by human intestinal microflora
50. Methylation of the estrogen receptor CpG island links aging and neoplasia in human colon